Differentiation of active multiple sclerosis lesions from non-active ones is done in the clinical environment by using contrast enhanced T1 images. CEST MRI has shown to yield correlations with Gadolinium contrast enhancement in tumors and other pathological tissue. In this work, we are trying to gain more insight in the metabolic information regarding the brain of patients suffering from multiple sclerosis.
This abstract and the presentation materials are available to members only; a login is required.